The total market value of cell based assay market is $11,744 million in 2020.
The forecast period for cell based assay market is 2021 to 2027
The market value of cell based assay market in 2030 is $26,345 million.
The base year is 2020 in cell based assay market.
Top companies such as, Bio-Rad, Danaher, Lonza, General Electric, Merck kGaA, and Promega held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
Drug discovery is the most influencing segment in cell based assay market as it has became a necessity for sufficient biological activity
The major factor that fuels the growth of the cell based assay market is the rise in drug discovery, surge in technological advancements and increased R&D investments.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 10.56%. This is due to rise in R&D fundings and surge in drug discovery.
Cell-based assays are viable experimental instruments in life sciences and bio manufacturing.
The cell based assays are used to show a cell's viability, proliferation, cytotoxicity, senescence, and death rate.
Loading Table Of Content...
Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?